3-(4-(4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butanoyl)phenyl)propyl acetate

ID: ALA378460

PubChem CID: 44411291

Max Phase: Preclinical

Molecular Formula: C33H39NO4

Molecular Weight: 513.68

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)OCCCc1ccc(C(=O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1

Standard InChI:  InChI=1S/C33H39NO4/c1-26(35)38-25-9-10-27-16-18-28(19-17-27)32(36)15-8-22-34-23-20-31(21-24-34)33(37,29-11-4-2-5-12-29)30-13-6-3-7-14-30/h2-7,11-14,16-19,31,37H,8-10,15,20-25H2,1H3

Standard InChI Key:  FSWBIKQBUVIPHY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
    6.8875  -22.4375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7125  -22.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5375  -22.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7125  -21.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7125  -23.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4272  -21.1983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4276  -20.3740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7126  -19.9607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9957  -20.3776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9989  -21.2005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9978  -23.6767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9974  -24.5010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7124  -24.9143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4293  -24.4974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4261  -23.6745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9488  -23.1538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7702  -23.1558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1865  -22.4431    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7753  -21.7268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9476  -21.7232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0115  -22.4462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4213  -23.1623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2463  -23.1654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6561  -23.8814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4811  -23.8845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2409  -24.5943    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.8867  -24.6028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7110  -24.6063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1270  -23.8928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7128  -23.1744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8899  -23.1745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9520  -23.8948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3627  -24.6103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1877  -24.6123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5985  -25.3278    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.1842  -26.0413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5950  -26.7568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3592  -26.0393    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  3 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 10  4  1  0
 18 21  1  0
  2  3  1  0
 21 22  1  0
  5 11  2  0
 22 23  1  0
  4  6  2  0
 23 24  1  0
 11 12  1  0
 24 25  1  0
  1  2  1  0
 24 26  2  0
 12 13  2  0
 25 27  2  0
  6  7  1  0
 27 28  1  0
 13 14  1  0
 28 29  2  0
  2  4  1  0
 29 30  1  0
 14 15  2  0
 30 31  2  0
 31 25  1  0
 15  5  1  0
 29 32  1  0
  3 16  1  0
 32 33  1  0
  7  8  2  0
 33 34  1  0
 34 35  1  0
  8  9  1  0
 35 36  1  0
  2  5  1  0
 36 37  1  0
  9 10  2  0
 36 38  2  0
M  END

Associated Targets(Human)

CYP2J2 Tchem Cytochrome P450 2J2 (258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 513.68Molecular Weight (Monoisotopic): 513.2879AlogP: 5.79#Rotatable Bonds: 12
Polar Surface Area: 66.84Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.22CX Basic pKa: 8.39CX LogP: 5.43CX LogD: 4.39
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.19Np Likeness Score: -0.31

References

1. Lafite P, Dijols S, Buisson D, Macherey AC, Zeldin DC, Dansette PM, Mansuy D..  (2006)  Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2.,  16  (10): [PMID:16495056] [10.1016/j.bmcl.2006.02.004]

Source